Last reviewed · How we verify
Intravenous infusion of ketamine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intravenous infusion of ketamine (Intravenous infusion of ketamine) — University Hospital, Basel, Switzerland.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravenous infusion of ketamine TARGET | Intravenous infusion of ketamine | University Hospital, Basel, Switzerland | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravenous infusion of ketamine CI watch — RSS
- Intravenous infusion of ketamine CI watch — Atom
- Intravenous infusion of ketamine CI watch — JSON
- Intravenous infusion of ketamine alone — RSS
Cite this brief
Drug Landscape (2026). Intravenous infusion of ketamine — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-infusion-of-ketamine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab